Search Results for "Early Presentation Of Polyhydramnios"
Original Source: Polyhydramnios hydramnios and oligohydramnios
Matching Channels
Matching News
Targeted therapy prevents rare neurodevelopmental disorder seizures
Rapamycin treatment reduces seizure frequency and improves receptive language in patients with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome, or Pretzel syndrome, a study finds.
Early IV nutrition for certain patients does improve survival or reduce ICU length of stay
The early (within 24 hours of intensive care unit [ICU] admission) provision of intravenous nutrition among critically ill patients with contraindications (a condition that makes a particular procedur...
Download: Presentation on ‘How to create a digital vision’
I thought you might interested in downloading a free presentation from this year’s DigiPharm event. The presentation by Timothy White, Digital Commercialization Head, Europe, Novartis, [...]
British 'stiff upper lip' may prevent early presentation for cancer symptoms
Embarrassment and not wanting to waste their doctors' time are more frequently reported by British people than in other countries, according to new research led jointly by King's College London and UC...
Cross-presentation by dendritic cells
This Review integrates recent evidence regarding the intracellular trafficking pathways involved in cross-presentation into our understanding of the role of cross-presentation in immunity and toleranc...
GTx Announces Webcast of Corporate Presentation at Bio CEO & Investor Conference
GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on February 11, 2013 at the Bio CEO & Investor Conference in New York City. The GTx pr...
Amarin Plays to Some Empty Seats at J.P. Morgan Confab
SAN FRANCISCO (TheStreet) --Amarin has begun wholesale inventory stocking of Vascepa in advance of a planned commercial launch of the triglyceride-lowering fish-oil pill at the end of January. That...
TG Therapeutics, Inc. Announces Poster Presentation Highlights for Ublituximab (TG-1101) and ...
Dr. Owen O'Connor Presents Early Clinical Data on the Safety and Efficacy From Two Ongoing Phase I Trials of TG-1101
Matching PubMed Articles
Prenatal presentation of transient central diabetes insipidus.
INTRODUCTION: Nephrogenic diabetes insipidus (DI) in the foetus has been described as a rare presentation of severe polyhydramnios. DISCUSSION: We report a case of foetal central DI, characterised by...
Case of polyhydramnios complicated by Opitz G/BBB syndrome.
Opitz G/BBB syndrome is a congenital disorder characterized by midline defects, such as hypertelorism, cleft lip and/or palate, hypospadias, and by dysphagia often caused by laryngo-tracheo-esophageal...
BACKGROUND: Aquaporins are a family of membrane-bound water channel proteins that regulate the flow of water across a variety of biological membranes. The expression of aquaporin 8 and aquaporin 9 has...
Clinical significance of amniotic fluid glucose concentration in polyhydramnios.
Abstract Objective: To evaluate whether amniotic fluid glucose concentration can predict poor neonatal outcome in cases with polyhydramnios as an overall assessment. Methods: In this retrospective stu...
Neonatal presentation of lethal neuromuscular glycogen storage disease type IV.
A total of 11 types of glycogen storage disorders have been recognized with variable clinical presentations. Type IV, also known as Andersen disease, represents a rare subtype that can induce severe c...
